Screener
iRadimed IRMD Amortization of extended maintenance agreements — Total Revenue
Other product segments
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by iRadimed in its filing.
Tagged under the XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.
The source filing: iRadimed’s 10-Q, filed May 1, 2026.
- Filed
- May 1, 2026, 4:08 PM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001628280-26-029325
| Line item | Three Months Ended March 31, 2026 | Three Months Ended March 31, 2025 |
|---|---|---|
| MRI Compatible Intravenous ("IV") Infusion Pump Systems | $7,664 | $5,999 |
| MRI Compatible Patient Vital Signs Monitoring Systems | 7,107 | 6,545 |
| Ferro Magnetic Detection Systems | 621 | 418 |
| Total devices revenue | 15,392 | 12,962 |
| Amortization of extended maintenance agreements | 659 | 560 |
| Disposables | 4,885 | 4,947 |
| Services and other | 1,043 | 1,042 |
| Total revenue | $21,979 | $19,511 |
Item 1. Condensed Financial Statements
FAQ
- What is iRadimed's amortization of extended maintenance agreements — total revenue?
- iRadimed (IRMD) reported amortization of extended maintenance agreements — total revenue of $659K in Q1 2026.
- What does amortization of extended maintenance agreements — total revenue mean?
- This metric represents the portion of total revenue recognized from the amortization of deferred service contract liabilities related to extended maintenance agreements for medical equipment. It reflects the systematic recognition of revenue over the life of service obligations provided to customers after the initial product sale. Tracking this helps investors understand the stability and recurring nature of the company's long-term service revenue streams.
Ask your AI about iRadimed's amortization of extended maintenance agreements — total revenue.
Connect your AI assistant and compare segments, right in your chat.
Connect your AI
Claude